前往化源商城

品牌现货直购

南通润丰石油化工有限公司
江苏省南通市崇川区
产品名：去氢表雄酮硫酸钠
纯度：0.0%
规格：1kg/25kg/200kg
联系人：曹经理

2143087160 复制
联系电话：17625439817

上海阿拉丁生化科技股份有限公司
上海市上海市浦东新区
产品名：去氢表雄酮硫酸钠
纯度：99.0%
规格：100mg/10mg/25mg/1g
联系人：阿拉丁

2881459338 复制
联系电话：400-620-6333

上海化源世纪贸易有限公司
上海市上海市普陀区
产品名：去氢表雄酮硫酸钠
纯度：98.0%
规格：
联系人：小陈

454578593 复制

18916513247 复制
联系电话：18916513247

查看所有供应商和价格请点击：

1099-87-2生产厂家

1099-87-2价格

1099-87-2

1099-87-2结构式

常用中文名：去氢表雄酮硫酸钠
常用英文名：Dehydroepiandrosterone sulfate sodium salt
CAS号：1099-87-2
分子式：C₁₉H₂₇NaO₅S
分子量：390.469
相关类别：原料药激素及调节内分泌功能类药雄激素及同化激素类药
发布时间：2018-08-29 15:39:38
更新时间：2026-07-12 17:31:45
Dehydroepiandrosterone sulfate sodium salt (DHEAS) 是人体中最丰富的的循环类固醇。Dehydroepiandrosterone sulfate sodium salt (DHEAS) 在分子水平上影响类固醇激素的生物合成,导致孕烯酮的增加。

化源商城直购

中文名	去氢表雄酮硫酸钠
英文名	Sodium prasterone sulfate
中文别名	硫酸普拉睾酮钠对照品脱氢表雄甾酮-3-磺酸钠水合物脱氢表雄酮硫酸钠标准品脱氢表雄酮硫酸钠脱氢表雄酮硫酸钠盐甲醇中脱氢表雄酮-[13C3]硫酸钠盐去氢表雄酮硫酸钠盐脱氢表雄酮硫酸钠盐 (DHEAS) 100UG/ML溶于甲醇 Dehydroiandrosterone Sulfate (DHEAS) Sodium Salt 去氢表雄酮硫酸钠 5-雄甾烯-3Β-醇-17-酮硫酸钠盐甲醇中脱氢表雄酮硫酸钠盐脱氢去氢雄激素硫酸盐(DHEAS) 去氢表雄酮硫酸钠二水合物硫酸普拉睾酮钠脱氢表雄甾酮-3-硫酸钠盐脱氢表雄酮硫酸钠盐(DHEAS)(2,3,C3,) 硫酸去氢雄甾酮硫酸盐(DHEAS)(2,3,C3,)100 UG / ML于甲醇中普拉雄酮硫酸钠脱氢表雄酮硫酸钠盐 (DHEAS) 1000 UG/ML溶于甲醇去氢表雄酮硫酸钠(硫酸普拉睾酮钠) 脱氢异雄甾酮-3-硫酸钠盐
英文别名	CUMYL-PEGACLONE(SGT-151) 3-(sulfooxy)-,sodiumsalt,(3-beta)-androst-5-en-17-on Androst-5-en-17-one, 3b-hydroxy-, hydrogen sulfate, sodium salt (6CI, 7CI, 8CI) sodiumandrost-5-en-17-one-3-beta-ylsulfate (3b)-3-(Sulfooxy)androst-5-en-17-one Sodium Salt Dehydroiandrosterone sulfate sodium salt hydrate (DHEA sulfate sodium hydrate) Sulfuric acid sodium 17-oxoandrosta-5-ene-3β-yl ester salt EINECS 214-152-2 DHEA sulfate,sodiuM salt Prasterone sulfate sodium DEHYDROISOANDROSTERONE 3-SULFATE, SODIUM SALT HYDRATE PRASTERONE SODIUM SULFATE SODIUM DEHYDROIANDROSTERONE SULFATE HYDRATE 3b-Hydroxy-5-androsten-17-one Sodium Sulfate sodium dehydroiandrosterone-3-sulfate sodium dehydroisoandrosterone-3-sulfate Natrium-(3β)-androst-5-en-17-on-3-sulfat DEHYDROISOANDROSTERONE SULFATE SODIUM 5-ANDROSTEN-3-BETA-OL-17-ONE SULPHATE, SODIUM SALT sodiumprasteronesulfate DEHYDROIANDROSTERONE SULFATE SODIUM 5-ANDROSTEN-3BETA-OL-17-ONE-3-SULFATE SODIUM dha-s Androst-5-en-17-one, 3-(sulfooxy)-, sodium salt, (3b)- (9CI) sodiumdehydroiandrosteronesulfate Androst-5-en-17-one, 3.beta.-hydroxy-, hydrogen sulfate, sodium salt PRASTERONE SULFATE SODIUM SALT 3b-Hydroxyandrost-5-en-17-one Hydrogen Sulfate Sodium Salt prasterone sodium sulphate Mylis Dehydroiandrosterone 3-sulfate sodium Sodium dehydroepiandrosterone sulfate SODIUM PRASTERONE SULFATE CAS NO.:1-2 DEHYDROIANDROSTERONE 3-SULFATE SODIUM SALT 3β-Hydroxyandrost-5-en-17-one sulfatesodium salt SODIUM PRASTERONR SULFATE Sodium prasterone sulfate //BP prasterone sulfate sodium salt sodium (3beta)-androst-5-en-17-one 3-sulphate 3β-(Sodiosulfooxy)androst-5-en-17-one 3-beta-hydroxy-androst-5-en-17-onesterwithsodiumsulfate mylis Prasterone Sulfate, Sodium salt(DHEA Sulfate, Sodium salt) 3β-[(Sodiooxysulfonyl)oxy]androsta-5-ene-17-one 5-ANDROSTEN-3BETA-OL-17-ONE SULFATE SODIUM SALT DEHYDROIANDROSTERONE-3-SULFATE SODIUM SALT HYDRATE DEHYDROIANDROSTERONE SODIUM SULFATE Dehydroiandrosterone-3-sulfate Sodium Salt Sodium Dehydroisoandrosterone-3-sulfate Dehydroiandrosterone-[13C3] Sulfate Sodium Salt in Methanol Dehydroiandrosterone Sulfate Sodium Salt in Methanol DEHYDROIANDROSTERONE SODIUM SULPHATE Sodium Prasterone Sulfate (1.0mg/ml in Acetonitrile) DEHYDROISOANDROSTERONE 3-SULFATE SODIUM SALT Teloin Androst-5-en-17-one, 3-(sulfooxy)-, sodium salt, (3β)- (1:1) androst-5-en-17-one,3-beta-hydroxy-,sulfate(ester),sodiumsalt Sodium (3β)-17-oxoandrost-5-en-3-yl sulfate Dehydroiandrosterone (Dhea) -0 / Sodium Sodium dehydroepiandrosterone-3-sulfate MFCD00010470 SGT-151(CUMYL-PEGACLONE) sodiumdehydroepiandrosteronesulfate SODIUM DEHYDROISOANDROSTERONE-3-SULFATE HYDRATE SODIUM DEHYDROIANDROSTERONE-3-SULFATE HYDRATE Dehydroepiandrosterone sulfate sodium Astenile DEHYDROIANDROSTERONE SULFATE SODIUM SALT Androst-5-en-17-one, 3-(sulfooxy)-, sodium salt, (3.beta.) Dehydroiandrosterone 3-sulfate (DHEAS) sodium salt solution Dehydroepiandrosterone-3-sulfate sodium salt

描述	Dehydroepiandrosterone sulfate sodium salt (DHEAS) 是人体中最丰富的的循环类固醇。Dehydroepiandrosterone sulfate sodium salt (DHEAS) 在分子水平上影响类固醇激素的生物合成,导致孕烯酮的增加。
相关类别	研究领域 >> 代谢疾病
靶点	Human Endogenous Metabolite
参考文献	[1]. Jens Neunzig, et al. Dehydroepiandrosterone Sulfate (DHEAS) Stimulates the First Step in the Biosynthesis of Steroid Hormones. PLoS One. 2014 Feb 21;9(2):e89727.

熔点	148-149 °C (dec.)(lit.)
分子式	C₁₉H₂₇NaO₅S
分子量	390.469
精确质量	390.147675
PSA	91.88000
LogP	4.44450
外观性状	白色至灰白色粉末
折射率	10 ° (C=4, MeOH)
储存条件	保持容器密封，储存在阴凉，干燥的地方
稳定性	常温常压下稳定，避免强氧化物接触
水溶解性	methanol: clear to hazy
分子结构	1、摩尔折射率：无可用的 2、摩尔体积（cm³/mol）：无可用的 3、等张比容（90.2K）：无可用的 4、表面张力（dyne/cm）：无可用的 5、介电常数：无可用的 6、极化率（10^-24cm³）：无可用的 7、单一同位素质量：390.147689 Da 8、标称质量：390 Da 9、平均质量：390.4694 Da
计算化学	1、氢键供体数量：0 2、氢键受体数量：5 3、可旋转化学键数量：2 4、互变异构体数量：2 5、拓扑分子极性表面积（TPSA）：83.5 6、重原子数量：26 7、表面电荷：0 8、复杂度：727 9、同位素原子数量：0 10、确定原子立构中心数量：6 11、不确定原子立构中心数量：0 12、确定化学键立构中心数量：0 13、不确定化学键立构中心数量：0 14、共价键单元数量：1
更多	1. 性状：白色粉末。 2. 密度（g/cm³,25℃）：未确定 3. 相对蒸汽密度（g/mL,空气=1）：未确定 4. 熔点（ºC）：148-149 5. 沸点（ºC,常压）：未确定 6. 沸点（ºC,2mm）：未确定 7. 折射率（°,MeOH）：10 8. 闪点（ºC）：未确定 9. 比旋光度（º）：未确定 10. 自燃点或引燃温度（ºC）：未确定 11. 蒸气压（mmHg,20ºC）：未确定 12. 饱和蒸气压（kPa,60ºC）：未确定 13. 燃烧热（KJ/mol）：未确定 14. 临界温度（ºC）：未确定 15. 临界压力（KPa）：未确定 16. 油水（辛醇/水）分配系数的对数值：未确定 17. 爆炸上限（%,V/V）：未确定 18. 爆炸下限（%,V/V）：未确定 19. 溶解性：溶于甲醇

CHEMICAL IDENTIFICATION

RTECS NUMBER :: BV8397400

CHEMICAL NAME :: Androst-5-en-17-one, 3-beta-hydroxy-, ester with sodium sulfate

CAS REGISTRY NUMBER :: 1099-87-2

LAST UPDATED :: 199806

DATA ITEMS CITED :: 21

MOLECULAR FORMULA :: C19-H27-O5-S.Na

MOLECULAR WEIGHT :: 390.51

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Human - woman

DOSE/DURATION :: 4 mg/kg

TOXIC EFFECTS :: Gastrointestinal - nausea or vomiting Skin and Appendages - dermatitis, other (after systemic exposure)

REFERENCE :: JMGZAI Japan Medical Gazette. (Tokyo, Japan) V.1-18(?), 1964-81. Discontinued. Volume(issue)/page/year: 18(5),10,1981

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: >10 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,687,1982

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 523 mg/kg

TOXIC EFFECTS :: Behavioral - altered sleep time (including change in righting reflex) Behavioral - ataxia Nutritional and Gross Metabolic - body temperature decrease

REFERENCE :: KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 10,1852,1976

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 1005 mg/kg

TOXIC EFFECTS :: Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Nutritional and Gross Metabolic - body temperature decrease

REFERENCE :: KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 10,1852,1976

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 468 mg/kg

TOXIC EFFECTS :: Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Lungs, Thorax, or Respiration - dyspnea

REFERENCE :: KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 10,1852,1976

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravaginal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: >500 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 48,189,1994

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: >10 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,687,1982

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 460 mg/kg

TOXIC EFFECTS :: Behavioral - altered sleep time (including change in righting reflex) Behavioral - ataxia Nutritional and Gross Metabolic - body temperature decrease

REFERENCE :: KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 10,1852,1976

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Subcutaneous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 899 mg/kg

TOXIC EFFECTS :: Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Nutritional and Gross Metabolic - body temperature decrease

REFERENCE :: KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 10,1852,1976

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravenous

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 274 mg/kg

TOXIC EFFECTS :: Behavioral - convulsions or effect on seizure threshold Behavioral - ataxia Lungs, Thorax, or Respiration - dyspnea

REFERENCE :: KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 10,1852,1976

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Intravaginal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: >500 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 48,189,1994 ** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 3 gm/kg/30D-I

TOXIC EFFECTS :: Blood - changes in other cell count (unspecified) Nutritional and Gross Metabolic - weight loss or decreased weight gain Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - phosphatases

REFERENCE :: KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 10,1857,1976

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 5460 mg/kg/26W-I

TOXIC EFFECTS :: Kidney, Ureter, Bladder - changes in bladder weight Blood - changes in erythrocyte (RBC) count Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - transaminases

REFERENCE :: KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 10,3016,1976

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 3200 mg/kg/32D-I

TOXIC EFFECTS :: Blood - changes in other cell count (unspecified) Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - transaminases Biochemical - Metabolism (Intermediary) - other proteins

REFERENCE :: KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 10,2989,1976

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: 18200 mg/kg/26W-I

TOXIC EFFECTS :: Liver - changes in liver weight Kidney, Ureter, Bladder - changes in bladder weight Blood - changes in other cell count (unspecified)

REFERENCE :: KSRNAM Kiso to Rinsho. Clinical Report. (Yubunsha Co., Ltd., 1-5, Kanda Suda-Cho, Chiyoda-ku, KS Bldg., Tokyo 101, Japan) V.1- 1960- Volume(issue)/page/year: 10,3001,1976 ** REPRODUCTIVE DATA **

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 500 mg/kg

SEX/DURATION :: female 8-17 day(s) after conception

TOXIC EFFECTS :: Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Effects on Newborn - live birth index (measured after birth)

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 12,201,1976

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 1 gm/kg

SEX/DURATION :: female 8-17 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - urogenital system

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 12,201,1976

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 100 mg/kg

SEX/DURATION :: female 8-17 day(s) after conception

TOXIC EFFECTS :: Reproductive - Specific Developmental Abnormalities - musculoskeletal system

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 12,201,1976

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 1 gm/kg

SEX/DURATION :: female 7-16 day(s) after conception

TOXIC EFFECTS :: Reproductive - Maternal Effects - parturition Reproductive - Specific Developmental Abnormalities - musculoskeletal system Reproductive - Specific Developmental Abnormalities - urogenital system

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 12,201,1976

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 3 gm/kg

SEX/DURATION :: female 7-16 day(s) after conception

TOXIC EFFECTS :: Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Newborn - sex ratio

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 12,201,1976

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Intraperitoneal

DOSE :: 100 mg/kg

SEX/DURATION :: female 7-16 day(s) after conception

TOXIC EFFECTS :: Reproductive - Effects on Embryo or Fetus - fetal death

REFERENCE :: OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 12,201,1976

符号	GHS02, GHS06, GHS08
信号词	Danger
危害声明	H225-H301 + H311 + H331-H370
警示性声明	P210-P260-P280-P301 + P310-P311
危害码 (欧洲)	F,C
风险声明 (欧洲)	R11
安全声明 (欧洲)	16-26-36/37/39-45
危险品运输编码	UN1230 - class 3 - PG 2 - Methanol, solution
WGK德国	3
RTECS号	BV8397400
闪点（华氏）	48.2 °F
闪点（摄氏）	9 °C

53-43-0结构式

53-43-0

~%

1099-87-2结构式

1099-87-2

文献：Chemistry and Biodiversity, , vol. 10, # 12 p. 2197 - 2208

上游产品 1
53-43-0
下游产品 1
53-43-0

本网页内容来自不同专业数据源，如对内容有疑义，欢迎联系service1@chemsrc.com。